Unlocking value for the patient in the consumer genomics market – a conversation with Robin Thurston

Today’s Guest: Robin Thurston | CEO of Helix

Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers.

Important links:

Helix Web Site: http://helix.com
Helix’ DNA Product Studio: https://www.prnewswire.com/news-releases/helix-announces-dna-product-studio-to-power-rapid-development-of-new-genomics-apps-and-tests-300733874.html
Robin’s LinkedIn: https://www.linkedin.com/in/robinthurston/
Robin on Twitter: https://twitter.com/RobinJThurston